Topic hub: muscle growth
Best Peptides for Muscle Growth: Ranked by Mechanism
Published by Peptara Labs · Updated · How we research and check our pages
Peptides for muscle growth: seven compounds ranked by mechanism proximity to hypertrophy. From direct GH/IGF-1 axis (CJC-1295/Ipamorelin, Tesamorelin) to training-volume enablers (BPC-157, TB-500) to energy and exercise-mimetic compounds (MOTS-c, SLU-PP-332). All research compounds. Peptara does not stock direct hypertrophy peptides (IGF-1 LR3, MGF, Follistatin-344); we explain why below.
Verdict in 7 lines
- CJC-1295/Ipamorelin: GHRH + GHRP combo pulses endogenous GH and IGF-1. Closest mechanism to direct hypertrophy in the catalog.
- Tesamorelin: GHRH analog alone. Sustained IGF-1 elevation. FDA-approved (Egrifta, 2010) for HIV-associated lipodystrophy.
- BPC-157: tendon and gut repair removes recovery bottlenecks, enabling more frequent and heavier mechanical loading.
- TB-500: muscle and soft-tissue repair, longer half-life systemic recovery.
- KLOW Combo: 4-peptide blend (BPC + TB-500 + GHK-Cu + KPV) for multi-site recovery in one vial.
- MOTS-c: mitochondrial AMPK activator. Insulin sensitivity and training-capacity support.
- SLU-PP-332: ERR agonist exercise mimetic. Preclinical mouse data; not validated for hypertrophy in humans.
Ranked by anabolic mechanism
Ordering reflects mechanism proximity to hypertrophy, not trial effect size. No head-to-head human hypertrophy trials exist across these compounds.
| Order | Peptide | Mechanism | Pathway to Hypertrophy | Evidence | Peptara Cost after the sale (email signup) |
|---|---|---|---|---|---|
| 1 | CJC-1295/Ipamorelin | GHRH analog + GHRP mimetic combo | Pulses endogenous GH, downstream IGF-1, MPS via PI3K/Akt/mTOR | Endocrinology literature; widely used research compound for GH/IGF-1 elevation | $84 to $169 with email signup |
| 2 | Tesamorelin | GHRH analog (no GHRP) | Sustained GH pulse, IGF-1 elevation, MPS support | FDA-approved 2010 (Egrifta, HIV lipodystrophy). Off-label / research for body composition. | about $440/mo with email signup |
| 3 | BPC-157 | Pro-angiogenic, growth-factor upregulation | Tendon/ligament/gut repair, enables increased training frequency and load tolerance | Extensive preclinical (Sikiric et al, 1990s to 2020s) | $89 to $177 with email signup |
| 4 | TB-500 | Actin-sequestering thymosin beta-4 fragment | Muscle and soft-tissue repair, systemic angiogenesis, longer half-life recovery | Preclinical plus equine clinical use plus human anecdote | $162 to $324 with email signup |
| 5 | KLOW Combo | 4-peptide systemic recovery blend (BPC + TB-500 + GHK-Cu + KPV) | Multi-site repair, single-vial convenience for systemic recovery between training blocks | Peptara stack formulation; literature on each individual peptide | $68 to $136 with email signup |
| 6 | MOTS-c | Mitochondrial-encoded peptide, AMPK activator | Mitochondrial biogenesis, insulin sensitivity, supports training capacity and protein-synthesis fueling | Lee et al, Cell Metab 2015; preclinical plus small human studies | $85 to $170 with email signup |
| 7 | SLU-PP-332 | ERR agonist exercise mimetic | Endurance and oxidative adaptation; hypertrophy data not primary endpoint | Billon et al, J Pharmacol Exp Ther 2023 (mouse only) | $157/vial with email signup, biohacker dosing varies |
Read this before quoting the ranking
Ordering reflects mechanism proximity to hypertrophy, not effect size. No head-to-head human hypertrophy trials exist across these compounds. The GH-axis tier is mechanistically closest to direct hypertrophy via IGF-1. The training-volume tier supports hypertrophy by enabling more frequent and heavier mechanical loading. The energy tier supports training capacity. All seven are research compounds. None are FDA-approved for hypertrophy.
Decide by training goal
Six goal profiles, six recommendations.
Goal A
Sleep-driven recovery + lean-mass retention
CJC-1295 (GHRH analog) plus Ipamorelin (GHRP mimetic) combo pulses endogenous GH during sleep, raising IGF-1 and supporting muscle protein synthesis. Nightly dosing aligns with the body's natural overnight GH window.
Pick: CJC-1295/Ipamorelin
No dedicated product page. WhatsApp for ordering.
Goal B
Sustained GH/IGF-1 + body recomposition
Tesamorelin is a GHRH analog alone (no GHRP). FDA-approved 2010 for HIV-associated lipodystrophy. Produces more sustained GH exposure than the CJC/Ipa pulse pattern. Daily dosing.
Pick: Tesamorelin
No dedicated product page. WhatsApp for ordering.
Goal C
Tendon and joint resilience for hard training
Body Protection Compound (BPC-157). Removes recovery bottlenecks at tendon, ligament, and joint sites so hypertrophy programming becomes the limiter again instead of soft-tissue injury.
Pick: BPC-157
Goal D
Multi-site recovery / returning from injury
KLOW Combo is a Peptara four-peptide blend (BPC-157 + TB-500 + GHK-Cu + KPV) in one vial. Convenience play for lifters with multiple recovery sites or returning from a layoff.
Pick: KLOW Combo
No dedicated product page. WhatsApp for ordering.
Goal E
Insulin sensitivity + training capacity
MOTS-c is a mitochondrial-encoded peptide that activates AMPK and drives mitochondrial biogenesis. Improves insulin sensitivity and supports training-capacity gains over weeks of dosing.
Pick: MOTS-c
No dedicated product page. WhatsApp for ordering.
Goal F
GH-axis + training-volume elite stack
CJC-1295/Ipamorelin (overnight GH pulse) plus BPC-157 (joint and tendon resilience). Most common muscle-growth stack for intermediate-to-advanced lifters running 4-plus sessions per week.
Pick: CJC-1295/Ipa + BPC-157
Mechanism tiers
Three tiers, seven compounds, ordered by mechanism distance to hypertrophy.
Tier 1: GH-axis
CJC-1295/Ipa + Tesamorelin
Closest mechanism to direct hypertrophy. Both compounds pulse endogenous growth hormone, which raises IGF-1, which drives muscle protein synthesis via the PI3K/Akt/mTOR pathway. CJC/Ipa uses a GHRH analog plus GHRP mimetic combo for pulsatile pulses; Tesamorelin is GHRH alone for sustained exposure.
Tier 2: Training-volume enablers
BPC-157 + TB-500 + KLOW
Indirect hypertrophy via recovery to mechanical loading to muscle protein synthesis. BPC-157 owns tendon and gut repair; TB-500 is a thymosin beta-4 fragment with broader systemic recovery and longer half-life; KLOW bundles BPC + TB-500 + GHK-Cu + KPV in one vial for multi-site repair.
Tier 3: Energy + exercise mimetic
MOTS-c + SLU-PP-332
Supports training capacity, not hypertrophy directly. MOTS-c activates AMPK and drives mitochondrial biogenesis. SLU-PP-332 is an ERR agonist with preclinical mouse data only. Best used as adjuncts, not primary mass-building agents.
Cost breakdown
The Black Friday sale puts every vial at 45% to 60% off until November 30, so the email-signup figures here are what applies after it. Peptara vial prices in USD, with the email-signup rate and retail shown. The monthly ranges span the low to high end of how much material a protocol uses; this page does not tell any person how much to take. For what the research on each compound describes, follow its product or guide link. Any decision belongs with a licensed physician.
| Peptide | Vial | Email signup / Retail, after the sale | Monthly range (email, after the sale) | Monthly range (regular retail) |
|---|---|---|---|---|
| CJC-1295/Ipa | 10mg | $130 / $153 | $84 to $169 | $99 to $199 |
| Tesamorelin | 20mg | $144 / $170 | about $216 | about $255 |
| BPC-157 | 20mg | $117 / $138 | $89 to $177 | $105 to $209 |
| TB-500 | 10mg | $187 / $220 | $162 to $324 | $190 to $381 |
| KLOW Combo | 80mg | $178 / $210 | $68 to $136 | $80 to $160 |
| MOTS-c | 40mg | $157 / $185 | $85 to $170 | $100 to $200 |
| SLU-PP-332 | 5mg | $157 / $185 | Varies | Varies |
Monthly cost calculation: vial price times 4.33 weeks/month divided by weeks per vial. Doses always in units, never mL. See the reconstitution guide for full math.
Stacking framework
Common stacks, specialty stacks, and sequencing rules.
Workhorse stacks
- CJC-1295/Ipa + BPC-157 (GH-axis pulse + tendon resilience)
- KLOW Combo + CJC-1295/Ipa (systemic recovery + GH pulse)
- Tesamorelin + MOTS-c (sustained GH/IGF-1 + metabolic flexibility for recomposition)
Specialty stacks
- TB-500 + CJC-1295/Ipa (muscle repair + GH pulse for high-volume blocks)
- KLOW Combo solo (single-vial multi-site recovery)
- Tesamorelin + BPC-157 (sustained GH + joint resilience for older lifters)
Sequencing
- Communities often pair a GH-axis compound with a recovery compound during higher-volume training; this page does not set when to start either
- Timing and cycle length are individual and belong with a clinician; no human hypertrophy trial establishes a cycle for these compounds
- Stacking logic is about mechanism, not dose: two GHRH analogs (CJC plus Tesamorelin) are redundant
- KLOW already contains BPC + TB-500, so pairing KLOW with separate BPC or TB-500 duplicates the same compounds
Why Peptara does not stock IGF-1 LR3, MGF, or Follistatin-344
Three peptides come up in every muscle-growth conversation: IGF-1 LR3 (Long R3 variant of insulin-like growth factor 1), MGF (Mechano Growth Factor, a splice variant of IGF-1 thought to drive satellite-cell activation post-mechanical damage), and Follistatin-344 (a myostatin inhibitor that theoretically removes the brake on muscle growth).
Peptara does not stock these. Three reasons.
- Thin human safety data. IGF-1 LR3 elevates IGF-1 supraphysiologically and the long-term safety profile of sustained IGF-1 elevation is not well-characterized in healthy adults.
- No FDA-approved indication for hypertrophy use. Means there is no regulatory pathway and no manufacturing oversight for finished pharmaceutical product in this category.
- High gray-market counterfeiting rate. For these three specific compounds relative to GLP-1s or BPC-157. We do not want to risk our COA program on compounds where the source pool is contaminated.
Our muscle-growth-relevant catalog (the seven SKUs ranked above) is the honest answer to "what does Peptara sell for muscle growth." It is not the maximalist answer.
Side effects by mechanism group
Three profiles to know. Notes below are not exhaustive.
GH-axis (CJC/Ipa, Tesamorelin)
Water retention, mild numbness or tingling in extremities (first 2 to 3 weeks), occasional vivid dreams. IGF-1 elevation with longer protocols, monitor labs over 3 months. Avoid in active malignancy and active diabetic retinopathy. Hypoglycemia risk if stacked with insulin or sulfonylureas.
Training-volume (BPC + TB + KLOW)
Generally well-tolerated. Injection-site reactions most common. Theoretical pro-angiogenic concerns in active or recent cancer (require physician oversight). KLOW includes KPV (anti-inflammatory tripeptide), and inherits each component's caveats.
Energy (MOTS-c, SLU-PP-332)
Limited human data overall. MOTS-c well-tolerated in small studies. SLU-PP-332 long-term human safety not established (preclinical mouse data only). Standard research-compound caveats apply.
Frequently asked questions
Which peptide is best for direct muscle growth?
No peptide in the Peptara catalog directly drives hypertrophy the way IGF-1 LR3, MGF (Mechano Growth Factor), or Follistatin-344 do in research literature. Peptara does NOT stock those three. The closest mechanism in our catalog is CJC-1295/Ipamorelin: it pulses endogenous growth hormone, which raises IGF-1, which drives muscle protein synthesis via the PI3K/Akt/mTOR pathway. Tesamorelin works the same axis (GHRH analog) without the GHRP component. The remaining peptides (BPC-157, TB-500, KLOW, MOTS-c, SLU-PP-332) support hypertrophy indirectly by enabling more training volume or improving training capacity.
Does Peptara sell IGF-1 LR3, MGF, or Follistatin?
No. Peptara does NOT stock IGF-1 LR3, MGF, or Follistatin-344. These are the three peptides most often discussed for direct hypertrophy in biohacker literature. We choose not to carry them because the human safety data is thin, no regulatory pathway exists for hypertrophy claims, and the gray-market counterfeit rate for these specific compounds is high. Our muscle-growth-relevant SKUs are listed above: CJC-1295/Ipamorelin and Tesamorelin (GH-axis), BPC-157, TB-500, KLOW Combo (training-volume), MOTS-c and SLU-PP-332 (energy / training capacity).
Are CJC-1295/Ipamorelin and Tesamorelin the same thing?
No. CJC-1295 is a GHRH analog and Ipamorelin is a GHRP mimetic; stacked together they synergize, with the GHRH amplifying GH pulse amplitude and the GHRP triggering the pulse. Tesamorelin is a GHRH analog alone (no GHRP). Tesamorelin has FDA approval (Egrifta, 2010, for HIV-associated lipodystrophy) and is administered daily on its label. CJC/Ipa is a research compound combo typically described as used nightly on an intermittent schedule. Both elevate IGF-1; Tesamorelin produces more sustained GH exposure, CJC/Ipa produces more pulsatile (more physiologic) GH release.
Can I run BPC-157 or TB-500 for muscle growth specifically?
BPC-157 and TB-500 do not directly drive hypertrophy. They drive recovery. The mechanism for hypertrophy here is indirect: faster recovery between training sessions allows more frequent and heavier mechanical loading, and mechanical loading is the proximate driver of muscle protein synthesis. If you cannot train hard because of tendinopathy, joint pain, or chronic soft-tissue injuries, these peptides remove the bottleneck and your hypertrophy programming becomes the limiter again. This is also why they appear on the recovery hub and the muscle-growth hub: same compound, different mechanism framing for different goals.
What is the best muscle-growth stack from the Peptara catalog?
For a hard-training lifter with intact joints: CJC-1295/Ipamorelin (GH-axis pulse during sleep) plus BPC-157 (tendon and joint resilience). For a lifter returning from injury or with multiple recovery sites: KLOW Combo (systemic recovery) plus CJC-1295/Ipamorelin (GH-axis support). For someone prioritizing body recomposition over pure mass: Tesamorelin (sustained GH/IGF-1) plus MOTS-c (insulin sensitivity and metabolic flexibility). All three stacks should be paired with a structured progressive-overload program, protein intake at 1.6 to 2.2g per kg body weight, and 7-plus hours of sleep nightly. The peptides are training-amplifiers, not training-replacements.
Are these peptides FDA-approved for muscle growth?
No. None of the seven peptides on this page is FDA-approved for muscle growth or hypertrophy as an indication. The brand drug Tesamorelin (Egrifta) is FDA-approved for HIV-associated lipodystrophy (a fat-distribution condition, not a hypertrophy indication); research-grade tesamorelin, including ours, is not an FDA-approved product. All other peptides on this page are research compounds. We are not making hypertrophy claims; we are describing mechanisms studied in research settings and ranges reported in published literature, presented for education only and not as a prescription. Consult a licensed physician before using any GH-axis peptide, especially if you have a history of cancer, diabetes, or pituitary dysfunction.
Can I stack GH-axis peptides with anabolic steroids?
Many lifters do. GH-axis peptides (CJC/Ipa, Tesamorelin) work via the endogenous growth hormone and IGF-1 pathway, which is mechanistically separate from the androgen receptor pathway that anabolic steroids activate. The two stacks can theoretically combine. However, both classes carry independent risk profiles: GH/IGF-1 elevation is associated with edema, carpal-tunnel symptoms, and theoretical malignancy risk; androgen use carries cardiovascular, lipid, hepatic, and HPTA-suppression concerns. We are not advising or facilitating steroid use. We are answering a question that comes up. Get blood work before, during, and after any combined protocol.
Is there a measured timeline for muscle growth on peptides?
No. Peptides do not add mass on top of poor training, and none of the studies listed on this page tracked muscle growth from these peptides week by week. Most of that evidence is in animals or small human groups (Sikiric et al for BPC-157; Lee et al, Cell Metab 2015 for MOTS-c), so it cannot tell any one person what they will see or when.
Next steps
BPC-157 product page
Body Protection Compound. 20mg/vial. $75 at its Black Friday price until November 30, $138 retail. The only muscle-growth-tier-3 peptide with a dedicated product page on Peptara.
View product
Peptide glossary
108 terms across pharmacology, units and measures, reconstitution, safety, regulatory, and mechanism. Anchors used on this page: IGF-1, GHRH, thymosin beta-4, AMPK, mitochondrial biogenesis, KPV, research compound.
Open glossary
Reconstitution guide
4-step method plus units-not-mL calculator. Required reading before any research-vial protocol.
Open guide
Full /vs/* cluster
Different goal? Switch hubs
Muscle-growth completes the body-composition trifecta. The other two hubs are:
Questions about the muscle-growth compounds
Message the Peptara team on WhatsApp and we will point you at what the research describes for each muscle-growth compound.
For CJC-1295/Ipamorelin, Tesamorelin, TB-500, KLOW Combo, MOTS-c, and SLU-PP-332 (no dedicated product page yet), WhatsApp is the order channel, and the team can send the batch certificate for what is in stock.